Dr Reddys Earnings Estimate

RDY Stock  USD 12.68  0.01  0.08%   
The next projected EPS of Dr Reddys is estimated to be 17.204625 with future projections ranging from a low of 16.67675 to a high of 17.7325. Dr Reddys' most recent 12-month trailing earnings per share (EPS TTM) is at 0.74. Please be aware that the consensus of earnings estimates for Dr Reddys Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Dr Reddys is projected to generate 17.204625 in earnings per share on the 31st of March 2025. Dr Reddys earnings estimates show analyst consensus about projected Dr Reddys Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on Dr Reddys' historical volatility. Many public companies, such as Dr Reddys, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Dr Reddys' earnings estimates, investors can diagnose different trends across Dr Reddys' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Dr Reddys' Gross Profit is fairly stable compared to the past year. Pretax Profit Margin is likely to rise to 0.24 in 2025, whereas Operating Profit Margin is likely to drop 0.11 in 2025.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Dr Reddys Earnings Estimation Breakdown

The calculation of Dr Reddys' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Dr Reddys is estimated to be 17.204625 with the future projection ranging from a low of 16.67675 to a high of 17.7325. Please be aware that this consensus of annual earnings estimates for Dr Reddys Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
16.94
16.68
Lowest
Expected EPS
17.204625
17.73
Highest

Dr Reddys Earnings Projection Consensus

Suppose the current estimates of Dr Reddys' value are higher than the current market price of the Dr Reddys stock. In this case, investors may conclude that Dr Reddys is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Dr Reddys' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
572.68%
16.9364
17.204625
0.74

Dr Reddys Earnings History

Earnings estimate consensus by Dr Reddys Laboratories analysts from Wall Street is used by the market to judge Dr Reddys' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Dr Reddys' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Dr Reddys Quarterly Gross Profit

49.05 Billion

At this time, Dr Reddys' Retained Earnings are fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.15 in 2025, whereas Earnings Yield is likely to drop 0.14 in 2025. Common Stock Shares Outstanding is likely to rise to about 1 B in 2025. Net Income Applicable To Common Shares is likely to rise to about 54.4 B in 2025.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dr Reddys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
11.1512.6914.23
Details
Intrinsic
Valuation
LowRealHigh
11.4114.2915.83
Details
Naive
Forecast
LowNextHigh
11.1412.6914.23
Details
5 Analysts
Consensus
LowTargetHigh
13.7815.1416.81
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of RDY assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Dr Reddys. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Dr Reddys' stock price in the short term.

Dr Reddys Earnings per Share Projection vs Actual

Actual Earning per Share of Dr Reddys refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Dr Reddys Laboratories predict the company's earnings will be in the future. The higher the earnings per share of Dr Reddys, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Dr Reddys Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Dr Reddys, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Dr Reddys should always be considered in relation to other companies to make a more educated investment decision.

RDY Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Dr Reddys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-01-28
2024-12-3116.15116.93640.7854
2024-10-25
2024-09-300.980.18-0.881 
2024-07-27
2024-06-3078.2283.465.24
2024-05-07
2024-03-3168.4578.359.914 
2024-01-30
2023-12-3170.4382.8112.3817 
2023-11-02
2023-09-3069.6588.9119.2627 
2023-07-26
2023-06-300.76991.030.260133 
2023-05-10
2023-03-310.640.70.06
2023-01-25
2022-12-310.580.910.3356 
2022-10-28
2022-09-300.570.820.2543 
2022-07-28
2022-06-300.520.90.3873 
2022-05-23
2022-03-310.550.07-0.4887 
2022-01-31
2021-12-310.860.57-0.2933 
2021-10-29
2021-09-300.5620.810.24844 
2021-07-27
2021-06-300.670.47-0.229 
2021-05-14
2021-03-310.510.46-0.05
2021-01-29
2020-12-310.520.02-0.596 
2020-10-28
2020-09-300.480.620.1429 
2020-07-29
2020-06-300.520.46-0.0611 
2020-05-20
2020-03-310.490.610.1224 
2020-01-27
2019-12-310.510.640.1325 
2019-11-01
2019-09-300.490.930.4489 
2019-07-29
2019-06-300.370.580.2156 
2019-05-17
2019-03-310.330.37250.042512 
2019-02-01
2018-12-310.320.40710.087127 
2018-10-26
2018-09-300.30.41310.113137 
2018-07-26
2018-06-300.270.39970.129748 
2018-05-22
2018-03-310.330.2671-0.062919 
2015-01-29
2014-12-310.450.530.0817 
2014-10-29
2014-09-300.460.5510.09119 
2014-07-30
2014-06-300.430.5390.10925 
2014-02-11
2013-12-310.450.540.0920 
2013-10-31
2013-09-300.460.650.1941 
2013-07-30
2013-06-300.430.36-0.0716 
2013-05-14
2013-03-310.540.60.0611 
2013-02-14
2012-12-310.550.4-0.1527 
2005-10-29
2005-09-300.060.130.07116 
2005-07-26
2005-06-300.060.05-0.0116 

About Dr Reddys Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Dr Reddys earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Dr Reddys estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Dr Reddys fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings305 B320.3 B
Earnings Yield 0.24  0.14 
Price Earnings Ratio 4.30  4.08 
Price Earnings To Growth Ratio 0.14  0.15 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.